Form 8-K

8-K — Quanex Building Products CORP

Accession: 0001171843-26-005882

Filed: 2026-09-03

Period: 2026-09-03

CIK: 0001423221

SIC: 3350 (ROLLING DRAWING & EXTRUDING OF NONFERROUS METALS)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — f8k_090326.htm (Primary)

EX-99.1 — PRESS RELEASE (exh_991.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: f8k_090326.htm · Sequence: 1

Form 8-K

False000142322100014232212026-09-032026-09-03iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 3, 2026

_______________________________

Quanex Building Products Corporation

(Exact name of registrant as specified in its charter)

_______________________________

Delaware 001-33913 26-1561397

(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

945 Bunker Hill Road, Suite 900

Houston, Texas 77024

(Address of Principal Executive Offices) (Zip Code)

(713) 961-4600

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Common Stock, par value $0.01 per share NX New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On September 3, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

99.1 Press Release dated September 3, 2026

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Quanex Building Products Corporation

Date: September 3, 2026 By: /s/ SCOTT ZUEHLKE

Scott Zuehlke

SVP, CFO and Treasurer

EX-99.1 — PRESS RELEASE

EX-99.1

Filename: exh_991.htm · Sequence: 2

EdgarFiling

EXHIBIT 99.1

Quanex Building Products Announces Third Quarter 2026 Results

Net Sales Growth

Volumes Continue to Track Normal Seasonality Patterns

Margin Expansion Realized in Hardware Solutions Segment and on Consolidated Basis

$42.25 Million of Debt Repaid in 3Q26

Continued Progress and Execution on Working Capital Management

HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended July 31, 2026.

The Company reported the following selected financial results:

Three Months Ended July 31, Nine Months Ended July 31,

($ in millions, except per share data) 2026 2025 2026 2025

Net Sales $501.8 $495.3 $1,373.3 $1,347.8

Gross Margin $141.5 $138.0 $357.8 $361.7

Gross Margin % 28.2% 27.9% 26.1% 26.8%

Operating Income (Loss) $46.5 ($270.8) $68.1 ($236.9)

Net Income (Loss) $26.5 ($276.0) $25.8 ($270.4)

Diluted EPS $0.58 ($6.04) $0.57 ($5.83)

Adjusted Net Income $36.0 $31.6 $47.0 $68.4

Adjusted Diluted EPS $0.79 $0.69 $1.03 $1.47

Adjusted EBITDA $72.7 $70.3 $144.3 $172.0

Adjusted EBITDA Margin % 14.5% 14.2% 10.5% 12.8%

Cash Provided By Operating Activities $58.6 $60.7 $57.3 $76.6

Free Cash Flow $47.8 $46.2 $24.2 $35.6

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, stated, “Volumes continued to track normal seasonality patterns during the third quarter of 2026, and we made meaningful progress addressing the price versus cost imbalance that impacted our margins in the second quarter of 2026. Inflationary pressures related to macroeconomic concerns and the ongoing conflict in the Middle East are still having an impact, but the initial rate and magnitude of these pressures have somewhat subsided.

“We stayed focused on managing our working capital during the third quarter of 2026, which when coupled with the seasonal uptick in volumes, enabled us to repay $42.25 million of debt and buy back some of our shares. We will continue to prioritize repaying debt and opportunistically repurchasing our shares as we generate cash in the fourth quarter of 2026. In addition, we will continue to identify operational efficiencies and commercial synergies that we believe will benefit us when consumer confidence and demand improve.”

Third Quarter 2026 Results Summary

Quanex reported net sales of $501.8 million during the three months ended July 31, 2026, which represents an increase of 1.3% compared to $495.3 million for the same period in 2025, mainly due to favorable impacts from pricing, partially offset by the impact of IEEPA tariff reimbursements to customers. The Hardware Solutions segments reported a 2.7% decline in net sales for the third quarter of 2026, driven by lower volumes and the impact of IEEPA tariff reimbursements to customers, which were somewhat offset by favorable impacts from pricing. The Extruded Solutions segments reported net sales growth of 2.8% for the third quarter of 2026, as lower volumes were more than offset by favorable impacts from pricing. Quanex reported an increase of 8.5% in net sales for the third quarter of 2026 in its Custom Solutions segment, largely due to increased volume and improved pricing. (See Sales Analysis table for additional information)

On a consolidated basis, the increase in reported earnings for the third quarter of 2026 compared to the third quarter of 2025 was mainly due to improved pricing, lower depreciation and amortization expense and lower interest expense. Results for the third quarter of 2025 were also impacted by a $302.3 million non-cash goodwill impairment.

Balance Sheet & Liquidity Update

As of July 31, 2026, the Company had total debt of $672.2 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA was 2.8x. As of July 31, 2026, Quanex reported LTM Net Income of $45.4 million and LTM Adjusted EBITDA of $215.2 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The Company’s liquidity increased by 10.5% to $363.1 million as of July 31, 2026, consisting of $62.1 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 99,786 shares of common stock for approximately $1.7 million at an average price of $17.10 per share during the three months ended July 31, 2026. As of July 31, 2026, approximately $28.7 million remained under the existing share repurchase authorization.

Conference Call and Webcast Information

The Company has scheduled a conference call for Friday, September 4, 2026, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link:

https://register-conf.media-server.com/register/BIac7900426be941999342c141e5049229

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently partners with leading OEMs to provide innovative solutions in window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflect operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. These measures allow management and investors to evaluate operational performance and trends without the impact of certain non-cash charges, acquisition-related costs, and other items that may vary significantly from period to period and may not be reflective of Quanex’s core operating results. The presented non-GAAP measures may not be the same as those used by other companies. The Company does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” “anticipate,” “intend,” “plan,” “project,” “seek,” “would,” “may,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: Quanex’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company’s industry, expectations regarding the recovery of price versus cost imbalances, anticipated debt repayment and share repurchase activity, expected operational efficiencies and synergies and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from those expressed or implied in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company’s future performance, please refer to Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

Three Months Ended July 31, Nine Months Ended July 31,

2026

2025

2026

2025

Net sales $ 501,845 $ 495,273 $ 1,373,301 $ 1,347,795

Cost of sales 360,380 357,305 1,015,517 986,129

Selling, general and administrative 70,837 71,270 216,695 208,253

Restructuring charges - 1,367 - 10,207

Depreciation and amortization 24,138 33,882 73,037 77,814

Asset impairment charges - 302,284 - 302,284

Operating income (loss) 46,490 (270,835 ) 68,052 (236,892 )

Interest expense (11,978 ) (14,218 ) (36,387 ) (42,344 )

Other, net (93 ) 855 5,972 1,925

Income (loss) before income taxes 34,419 (284,198 ) 37,637 (277,311 )

Income tax (expense) benefit (7,915 ) 8,191 (11,854 ) 6,934

Net income (loss) $ 26,504 $ (276,007 ) $ 25,783 $ (270,377 )

Earnings (loss) per common share, basic $ 0.58 $ (6.04 ) $ 0.57 $ (5.83 )

Earnings (loss) per common share, diluted $ 0.58 $ (6.04 ) $ 0.57 $ (5.83 )

Weighted average common shares outstanding:

Basic 45,461 45,691 45,466 46,395

Diluted 45,648 45,691 45,607 46,395

Cash dividends per share $ 0.08 $ 0.08 $ 0.24 $ 0.24

QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

July 31, 2026 October 31, 2025

ASSETS

Current assets:

Cash and cash equivalents $ 62,094 $ 76,018

Restricted Cash 2,123 2,100

Accounts receivable, net 214,768 205,384

Inventories 276,396 254,122

Income taxes receivable 5,603 -

Prepaid assets 37,452 32,387

Other current assets 3,847 3,764

Total current assets 602,283 573,775

Property, plant and equipment, net 394,021 411,591

Operating lease right-of-use assets 171,552 154,866

Deferred tax assets 300 2,706

Goodwill 273,765 271,346

Intangible assets, net 522,218 549,137

Other assets 4,552 4,812

Total assets $ 1,968,691 $ 1,968,233

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable $ 127,030 $ 131,307

Accrued liabilities 88,209 95,155

Income taxes payable 9,300 12,076

Current maturities of long-term debt 26,551 27,561

Current operating lease liabilities 18,822 15,446

Other liabilities - -

Total current liabilities 269,912 281,545

Long-term debt 636,814 665,268

Noncurrent operating lease liabilities 160,290 145,459

Deferred pension benefits

Deferred income taxes 137,766 135,993

Liabilities for uncertain tax positions 1,857 -

Other liabilities 16,608 13,789

Total liabilities 1,223,247 1,242,054

Stockholders’ equity:

Common stock 512 512

Additional paid-in-capital 697,598 700,029

Retained earnings 179,472 164,710

Accumulated other comprehensive loss (32,142 ) (35,439 )

Treasury stock at cost (99,996 ) (103,633 )

Total stockholders’ equity 745,444 726,179

Total liabilities and stockholders' equity $ 1,968,691 $ 1,968,233

QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(In thousands)

(Unaudited)

Nine Months Ended July 31,

2026

2025

Operating activities:

Net (loss) income $ 25,783 $ (270,377 )

Adjustments to reconcile net loss to cash used for operating activities:

Depreciation and amortization 73,037 77,814

Stock-based compensation 3,617 2,762

Deferred income tax 664 (26,440 )

Goodwill impairment charge - 302,284

Other, net 4,640 9,203

Changes in assets and liabilities:

Increase in accounts receivable (8,685 ) (1,727 )

(Increase) decrease in inventory (21,129 ) 5,261

Increase in other current assets (4,430 ) (7,228 )

(Decrease) increase in accounts payable (2,365 ) 144

Decrease in accrued liabilities (7,601 ) (9,725 )

Change in income taxes (6,629 ) (21 )

Other, net 366 (5,307 )

Cash provided by operating activities 57,268 76,643

Investing activities:

Capital expenditures (33,066 ) (40,996 )

Proceeds from disposition of capital assets 62 361

Cash used for investing activities (33,004 ) (40,635 )

Financing activities:

Borrowings under credit facilities 141,500 170,000

Repayments of credit facility borrowings (164,250 ) (213,750 )

Repayments of other long-term debt (3,316 ) (1,962 )

Common stock dividends paid (10,916 ) (11,233 )

Purchase of treasury stock (1,707 ) (29,248 )

Other, net (704 ) (1,186 )

Cash used for financing activities (39,393 ) (87,379 )

Effect of exchange rate changes on cash and cash equivalents 1,228 16,302

Decrease in cash, cash equivalents and restricted cash (13,901 ) (35,069 )

Cash, cash equivalents and restricted cash at beginning of period 78,118 102,995

Cash, cash equivalents and restricted cash at end of period $ 64,217 $ 67,926

QUANEX BUILDING PRODUCTS CORPORATION

FREE CASH FLOW AND NET DEBT RECONCILIATION

(In thousands)

(Unaudited)

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

Three Months Ended July 31,

Nine Months Ended July 31,

2026

2025

2026

2025

Cash provided by operating activities $ 58,554 $ 60,656 $ 57,268 $ 76,643

Capital expenditures (10,744 ) (14,452 ) (33,066 ) (40,996 )

Free Cash Flow $ 47,810 $ 46,204 $ 24,202 $ 35,647

The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

As of July 31,

2026

2025

Term loan facility $ 450,000 $ 475,000

Revolving credit facility 168,500 197,500

Finance lease obligations (1) 53,697 61,194

Total debt (2) 672,197 733,694

Less: Cash and cash equivalents 62,094 66,272

Net Debt $ 610,103 $ 667,422

(1) Includes $47.9 million and $58.9 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2026 and 2025, respectively.

(2) Excludes outstanding letters of credit.

QUANEX BUILDING PRODUCTS CORPORATION

NON-GAAP FINANCIAL MEASURE DISCLOSURE

LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION

(In thousands, except per share data)

(Unaudited)

Reconciliation of Last Twelve Months Adjusted EBITDA Three Months Ended July 31, 2026

Three Months Ended April 30, 2026 Three Months Ended January 31, 2026 Three Months Ended October 31, 2025 Total

Reconciliation

Reconciliation Reconciliation Reconciliation Reconciliation

Net income (loss) as reported $ 26,504 $ 3,350 $ (4,071 ) $ 19,571 $ 45,354

Income tax expense (benefit) 7,915 3,766 173 15,147 27,001

Other, net 93 (448 ) (5,617 ) (5,246 ) (11,218 )

Interest expense 11,978 12,042 12,367 13,468 49,855

Depreciation and amortization 24,138 24,650 24,249 25,630 98,667

EBITDA 70,628 43,360 27,101 68,570 209,659

Cost of sales (1) 1,223 121 407 308 2,059

Selling, general and administrative (1),(2) 894 688 (126 ) 2,040 3,496

Adjusted EBITDA $ 72,745 $ 44,169 $ 27,382 $ 70,918 $ 215,214

(1) Severance and other expenses related to manufacturing footprint and performance optimization.

(2) Transaction, advisory fees, severance and reorganization costs.

QUANEX BUILDING PRODUCTS CORPORATION

NON-GAAP FINANCIAL MEASURE DISCLOSURE

(In thousands, except per share data)

(Unaudited)

Reconciliation of Adjusted Net Income and Adjusted EPS Three Months Ended July 31, 2026 Three Months Ended July 31, 2025 Nine Months Ended July 31, 2026 Nine Months Ended July 31, 2025

Net Income Diluted EPS Net Income Diluted EPS Net Income Diluted EPS Net Income Diluted EPS

Net income (loss) as reported $ 26,504 $ 0.58 $ (276,007 ) $ (6.04 ) $ 25,783 $ 0.57 $ (270,377 ) $ (5.83 )

Net income(loss) reconciling items from below 9,507 $ 0.21 307,578 $ 6.73 21,221 $ 0.46 338,756 $ 7.30

Adjusted net income and adjusted EPS $ 36,011 $ 0.79 $ 31,571 $ 0.69 $ 47,004 $ 1.03 $ 68,379 $ 1.47

Reconciliation of Adjusted EBITDA Three Months Ended July 31, 2026 Three Months Ended July 31, 2025 Nine Months Ended July 31, 2026 Nine Months Ended July 31, 2025

Reconciliation Reconciliation Reconciliation Reconciliation

Net income (loss) as reported $ 26,504 $ (276,007 ) $ 25,783 $ (270,377 )

Income tax expense 7,915 (8,191 ) 11,854 (6,934 )

Other, net 93 (855 ) (5,972 ) (1,925 )

Interest expense 11,978 14,218 36,387 42,344

Depreciation and amortization 24,138 33,882 73,037 77,814

Asset impairment charges - 302,284 - 302,284

EBITDA 70,628 65,331 141,089 143,206

EBITDA reconciling items from below 2,117 4,964 3,207 28,766

Adjusted EBITDA $ 72,745 $ 70,295 $ 144,296 $ 171,972

Reconciling Items Three Months Ended July 31, 2026 Three Months Ended July 31, 2025 Nine Months Ended July 31, 2026 Nine Months Ended July 31, 2025

Income Statement Reconciling Items Income Statement Reconciling Items Income Statement Reconciling Items Income Statement Reconciling Items

Net sales $ 501,845 $ - $ 495,273 $ - $ 1,373,301 $ - $ 1,347,795 $ -

Cost of sales 360,380 (1,223 ) (1) 357,305 (148 ) (1) 1,015,517 (1,751 ) (1) 986,129 (1,124 ) (1)

Selling, general and administrative 70,837 (894 ) (1),(3) 71,270 (3,449 ) (1),(3) 216,695 (1,456 ) (1),(3) 208,253 (17,435 ) (1),(2),(3)

Restructuring charges - - 1,367 (1,367 ) (4) - - 10,207 (10,207 ) (4)

EBITDA 70,628 2,117 65,331 4,964 141,089 3,207 143,206 28,766

Asset impairment charges - - 302,284 (302,284 ) (5) - - 302,284 (302,284 ) (5)

Depreciation and amortization 24,138 (9,758 ) (6) 33,882 (19,604 ) (6) 73,037 (29,291 ) (6) 77,814 (36,708 ) (6)

Operating income (loss) 46,490 11,875 (270,835 ) 326,852 68,052 32,498 (236,892 ) 367,758

Interest expense (11,978 ) - (14,218 ) - (36,387 ) - (42,344 ) -

Other, net (93 ) 288 (7) 855 (949 ) (7) 5,972 (4,942 ) (7) 1,925 (118 ) (7)

Income (loss) before income taxes 34,419 12,163 (284,198 ) 325,903 37,637 27,556 (277,311 ) 367,640

Income tax (expense) benefit (7,915 ) (2,656 ) (8) 8,191 (18,325 ) (8) (11,854 ) (6,335 ) (8) 6,934 (28,884 ) (8)

Net income (loss) $ 26,504 9,507 $ (276,007 ) $ 307,578 $ 25,783 21,221 $ (270,377 ) $ 338,756

Diluted earnings (loss) per share $ 0.58 $ (6.04 ) $ 0.57 $ (5.83 )

(1) Severance and other expenses related to manufacturing footprint and performance optimization.

(2) Amortization of step-up for purchase price adjustments on inventory.

(3) Transaction, advisory fees, and severance and reorganization costs.

(4) Restructuring charges related to severance and disposal of software.

(5) Goodwill impairment.

(6) Amortization expense related to intangible assets.

(7) Foreign currency transaction (gains) losses.

(8) Tax impact of net income reconciling items.

QUANEX BUILDING PRODUCTS CORPORATION

SELECTED SEGMENT DATA

(In thousands)

(Unaudited)

This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.

Hardware Solutions Extruded Solutions Custom Solutions Unallocated Corp & Other Total

Three months ended July 31, 2026

Net sales $ 220,923 $ 179,291 $ 111,007 $ (9,376 ) $ 501,845

Cost of sales 162,056 121,389 85,861 (8,926 ) 360,380

Gross Margin 58,867 57,902 25,146 (450 ) 141,465

Gross Margin % 26.6 % 32.3 % 22.7 % 28.2 %

Selling, general and administrative (1) 33,162 22,279 13,143 2,253 70,837

Depreciation and amortization 11,386 7,213 5,330 209 24,138

Operating (loss) income 14,319 28,410 6,673 (2,912 ) 46,490

Depreciation and amortization 11,386 7,213 5,330 209 24,138

EBITDA 25,705 35,623 12,003 (2,703 ) 70,628

Expense related to plant relocation and closure (Cost of sales) 1,223 - - - 1,223

Reorganization and severance costs 127 1 - 766 894

Adjusted EBITDA $ 27,055 $ 35,624 $ 12,003 $ (1,937 ) $ 72,745

Adjusted EBITDA Margin % 12.2 % 19.9 % 10.8 % 14.5 %

Three months ended July 31, 2025

Net sales $ 227,116 $ 174,427 $ 102,264 $ (8,534 ) $ 495,273

Cost of sales 170,282 116,597 77,755 (7,329 ) 357,305

Gross Margin 56,834 57,830 24,509 (1,205 ) 137,968

Gross Margin % 25.0 % 33.2 % 24.0 % 27.9 %

Selling, general and administrative (1) 32,954 20,740 11,708 5,868 71,270

Restructuring charges 1,140 34 26 167 1,367

Depreciation and amortization 16,987 6,989 4,716 5,190 33,882

Asset impairment charges 163,198 54,934 84,152 - 302,284

Operating income (loss) (157,445 ) (24,867 ) (76,093 ) (12,430 ) (270,835 )

Depreciation and amortization 16,987 6,989 4,716 5,190 33,882

Asset impairment charges 163,198 54,934 84,152 - 302,284

EBITDA 22,740 37,056 12,775 (7,240 ) 65,331

Expense related to plant relocation and closure (Cost of sales) 148 - - - 148

Transaction, advisory fees, reorganization costs, and product recall expenses 715 - 50 2,684 3,449

Restructuring charges 1,140 34 26 167 1,367

Adjusted EBITDA $ 24,743 $ 37,090 $ 12,851 $ (4,389 ) $ 70,295

Adjusted EBITDA Margin % 10.9 % 21.3 % 12.6 % 14.2 %

Nine months ended July 31, 2026

Net sales $ 613,054 $ 484,040 $ 304,062 $ (27,855 ) $ 1,373,301

Cost of sales 475,172 331,979 236,302 (27,936 ) 1,015,517

Gross Margin 137,882 152,061 67,760 81 357,784

Gross Margin % 22.5 % 31.4 % 22.3 % 26.1 %

Selling, general and administrative (1) 103,105 65,084 40,182 8,324 216,695

Depreciation and amortization 34,626 21,893 15,956 562 73,037

Operating (loss) income 151 65,084 11,622 (8,805 ) 68,052

Depreciation and amortization 34,626 21,893 15,956 562 73,037

EBITDA 34,777 86,977 27,578 (8,243 ) 141,089

Expense related to plant relocation and closure (Cost of sales) 1,751 - - - 1,751

Credit related to plant relocation (SG&A) (8 ) - - - (8 )

Reorganization and severance costs 273 1 1 1,189 1,464

Adjusted EBITDA $ 36,793 $ 86,978 $ 27,579 $ (7,054 ) $ 144,296

Adjusted EBITDA Margin % 6.0 % 18.0 % 9.1 % 10.5 %

Nine months ended July 31, 2025

Net sales $ 614,791 $ 478,024 $ 284,809 $ (29,829 ) $ 1,347,795

Cost of sales 466,600 325,914 219,755 (26,140 ) 986,129

Gross Margin 148,191 152,110 65,054 (3,689 ) 361,666

Gross Margin % 24.1 % 31.8 % 22.8 % 26.8 %

Selling, general and administrative (1) 98,570 60,921 34,156 14,606 208,253

Restructuring charges 8,155 34 26 1,992 10,207

Depreciation and amortization 38,818 22,066 15,693 1,237 77,814

Asset impairment charges 163,198 54,934 84,152 - 302,284

Operating (loss) income (160,550 ) 14,155 (68,973 ) (21,524 ) (236,892 )

Depreciation and amortization 38,818 22,066 15,693 1,237 77,814

Asset impairment charges 163,198 54,934 84,152 - 302,284

EBITDA 41,466 91,155 30,872 (20,287 ) 143,206

Expense related to plant closure (Cost of sales) 1,124 - - - 1,124

Gain related to plant closure (SG&A) 247 - - - 247

Amortization of step-up for purchase price adjustments on inventory and accounts receivable 7,276 1,428 302 - 9,006

Transaction and advisory fees 1,397 177 50 6,558 8,182

Restructuring charges 8,155 34 26 1,992 10,207

Adjusted EBITDA $ 59,665 $ 92,794 $ 31,250 $ (11,737 ) $ 171,972

Adjusted EBITDA Margin % 9.7 % 19.4 % 11.0 % 12.8 %

(1) Includes stock-based compensation expense for the three and nine months ended July 31 2026 of $0.9 million and 5.5 million, respectively, and $1.8 million and $3.6 million for the comparable prior year periods.

QUANEX BUILDING PRODUCTS CORPORATION

SALES ANALYSIS

(In thousands)

(Unaudited)

Three Months Ended July 31,

Nine Months Ended July 31,

2026

2025

2026

2025

Hardware Solutions:(1)

Window and door hardware $ 133,038 $ 148,303 $ 387,047 $ 405,497

Screens 85,830 76,809 219,980 203,269

Other 2,055 2,004 6,027 6,025

$ 220,923 $ 227,116 $ 613,054 $ 614,791

Extruded Solutions:(2)

Window profiles $ 75,684 $ 76,775 $ 206,581 $ 206,629

Seals and gaskets 20,241 20,415 57,405 57,857

Spacers 59,996 55,201 160,124 148,733

Solar 5,375 5,250 15,292 17,835

Flashing Tape 2,821 3,038 7,567 6,751

Window and door hardware 10,079 10,676 26,061 31,311

Other 5,095 3,072 11,010 8,908

$ 179,291 $ 174,427 $ 484,040 $ 478,024

Custom Solutions:(3)

Wood solutions $ 59,282 $ 53,409 $ 162,841 $ 148,456

Access solutions 29,483 27,370 78,984 74,158

Mixing solutions 22,242 21,485 62,237 62,195

$ 111,007 $ 102,264 $ 304,062 $ 284,809

Unallocated Corporate & Other:

Eliminations $ (9,376 ) $ (8,534 ) $ (27,855 ) $ (29,829 )

$ (9,376 ) $ (8,534 ) $ (27,855 ) $ (29,829 )

Net Sales $ 501,845 $ 495,273 $ 1,373,301 $ 1,347,795

(1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.

(2) Reflects an unfavorable $0.1 million and favorable $8.3 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.

(3) Reflects no impact and favorable $0.3 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Sep. 03, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 03, 2026

Entity File Number

001-33913

Entity Registrant Name

Quanex Building Products Corporation

Entity Central Index Key

0001423221

Entity Tax Identification Number

26-1561397

Entity Incorporation, State or Country Code

Entity Address, Address Line One

945 Bunker Hill Road, Suite 900

Entity Address, City or Town

Houston

Entity Address, State or Province

Entity Address, Postal Zip Code

77024

City Area Code

713

Local Phone Number

961-4600

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.01 per share

Trading Symbol

Security Exchange Name

NYSE

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration